Ulrik Lassen - Dissemin

Papers authored by Ulrik Lassen

This paper is made freely available by the publisher.

2014 Mette Villingshøj, Hans Skovgaard Poulsen, Poulsen,Hans Skovgaard, Villingshoej,Mette, Urup,Thomas, Thomas Urup, Michaelsen,Signe, Signe Regner Michaelsen, Staberg,Mikkel, Mikkel Staberg, Lassen,Ulrik, Ulrik Lassen

, Mette Villingshoej

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

Download from dx.doi.org

This paper was not found in any repository, but could be made available legally by the author.

Ida Viller Tuxen, Lars Jønson, Eric Santoni-Rugiu, Jane Preuss Hasselby, Finn Cilius Nielsen, Ulrik Lassen

Personalized oncology: genomic screening in phase 1

Upload

Mette K. Nedergaard, Karina Kristoffersen, Signe R. Michaelsen, Jacob Madsen, Hans S. Poulsen, Marie-Thérése Stockhausen, Ulrik Lassen

, Andreas Kjaer

The Use of Longitudinal 18F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts

Download from doi.org

M. Grunnet

, I. J. Christensen, U. Lassen

, L. H. Jensen, M. Lydolph, I. K. Lund, T. Thurison, G. Høyer-Hansen, M. Mau-Sørensen

Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients

Upload

Distributing this paper is prohibited by the publisher

Kenneth F. Hofland, Steinbjørn Hansen, Morten Sorensen, Silke Engelholm, Henrik P. Schultz, Aida Muhic, Kirsten Grunnet, Anders Ask, Junia C. Costa, Charlotte Kristiansen, Carsten Thomsen, Hans Skovgaard Poulsen, Ulrik N. Lassen

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

Upload

2013 Karen-Lise G. Spindler, Morten M. Sorensen, Niels Pallisgaard, Rikke F. Andersen, Birgitte M. Havelund, John Ploen, Ulrik Lassen

, Anders K. M. Jakobsen

Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma

Upload

Anne Helene Køstner

, Morten Sorensen, René Krøjgaard Olesen, Henning Grønbæk, Ulrik Lassen

, Morten Ladekarl

Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability

Download from downloads.hindawi.com

This paper is available in a repository.

Rikke Søgaard, Barbara Malene Bjerregaard Fischer

, Jann Mortensen

, Torben Riis Rasmussen, Ulrik Lassen

The Optimality of Different Strategies for Supplemental Staging of Non-Small-Cell Lung Cancer: A Health Economic Decision Analysis

Download from www.researchgate.net

C. M. L. van Herpen, Carla M. L. van Herpen, Ulrik Lassen

, Ingrid M. E. Desar, Kathryn H. Brown, Marcelo Marotti, Maja J. A. de Jonge, M. J. de Jonge

Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

Upload

2012 U. Lassen

, W. H. Miller, S. Hotte, T. R. J. Evans, C. Kollmansberger, D. Adamson, D. L. Nielsen, J. Spicer

, E. Chen, T. Meyer, K. Brown, R. Rafi, M. B. Sawyer

Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours

Upload

Aida Muhic, Hans Skovgaard Poulsen, Morten Sorensen, Kirsten Grunnet, Ulrik Lassen

Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme

Upload

Don S. Dizon, Lars Damstrup, Neil J. Finkler, Ulrik Lassen

, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S. Lichenstein, Poul Knoblach, Richard T. Penson

Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer:

Upload

Søren Møller, Kirsten Grunnet, Steinbjørn Hansen, Henrik Schultz, Mats Holmberg, Morten Sorensen, Hans S. Poulsen, Ulrik Lassen

A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy

Download from www.tandfonline.com

U. Lassen

, D. L. Nielsen, M. Sørensen, L. Winstedt, T. Niskanen, Y. Stenberg, S. Pakola, J.-M. Stassen, S. A. Glazer

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours

Download from www.nature.com

2011 Kristoffer S. Rohrberg, René K. Olesen, Per Pfeiffer, Morten Ladekarl, Helle Pappot, Ib J. Christensen, Gunilla Høyer-Hansen, Morten Sørensen, Birgit G. Skov, Ian Buysschaert, Peter Carmeliet, Ulrik Lassen

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

Download from www.researchgate.net

Kristoffer Staal Rohrberg, Helle Pappot, Ulrik Lassen

, Maj Westman, René K. Olesen, Per Pfeiffer, Morten Ladekarl, Morten Sørensen, Ib J. Christensen, Birgit G. Skov

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab

Download from www.tandfonline.com

Jan Nyrop Jakobsen, Benedikte Hasselbalch, Marie-Thérése Stockhausen, Ulrik Lassen

, Hans Skovgaard Poulsen

Irinotecan and bevacizumab in recurrent glioblastoma multiforme

Upload

Barbara M. Fischer

, Ulrik Lassen

, Liselotte Højgaard

PET-CT in preoperative staging of lung cancer

Upload

Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen

, Ib Jarle Christensen, Gunilla Høyer-Hansen, Ian Buysschaert, Helle Pappot

Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer

Upload

Rikke Søgaard, Barbara Malene B. Fischer

, Jann Mortensen

, Liselotte Højgaard, Ulrik Lassen

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Ulrik Lassen